{"rows":[{"id":2211,"title":"Psychedelic Medicines in Major Depression: Progress and Future Challenges.","authors":"Bouso JC, Ona G, Dos Santos RG, Hallak JEC","journal":"Advances in experimental medicine and biology","publication_date":"2021-01-01","publication_year":2021,"doi":"10.1007/978-981-33-6044-0_26","pubmed_id":"33834416","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/33834416/","substance_tags":"psilocybin","topic_tags":"Depression,Mechanism of Action,Clinical Trial,Safety","study_type":"Clinical Trial","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:54:14","last_checked":"2026-08-09 08:28:23","bibtex":null,"source_record_id":"PMID:33834416","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/33834416/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:33834416","source_url":"https://pubmed.ncbi.nlm.nih.gov/33834416/","doi":"10.1007/978-981-33-6044-0_26","pmid":"33834416","publication_date":"2021-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":1268,"title":"Efficacy, Safety, and Tolerability of Psychedelics in Treatment-Resistant Depression (TRD).","authors":"Olivier B, Olivier JDA","journal":"Advances in experimental medicine and biology","publication_date":"2024-01-01","publication_year":2024,"doi":"10.1007/978-981-97-4402-2_3","pubmed_id":"39261423","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/39261423/","substance_tags":"psilocybin","topic_tags":"Depression,Mechanism of Action,Receptor Pharmacology,Treatment-Resistant Depression,Safety","study_type":"Other","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:05","last_checked":"2026-08-09 08:28:11","bibtex":null,"source_record_id":"PMID:39261423","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/39261423/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:39261423","source_url":"https://pubmed.ncbi.nlm.nih.gov/39261423/","doi":"10.1007/978-981-97-4402-2_3","pmid":"39261423","publication_date":"2024-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":340,"title":"New Antidepressant Development in the Treatment of Depression.","authors":"Spiti A, Caldirola D, Perna G","journal":"Advances in experimental medicine and biology","publication_date":"2026-01-01","publication_year":2026,"doi":"10.1007/978-981-95-6872-7_23","pubmed_id":"42036580","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/42036580/","substance_tags":"psilocybin","topic_tags":"Depression,Addiction,Mechanism of Action,Receptor Pharmacology,Biomarkers,Clinical Trial,Animal Study,Safety,Adverse Events","study_type":"Clinical Trial","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:04","last_checked":"2026-08-09 08:27:53","bibtex":null,"source_record_id":"PMID:42036580","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/42036580/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:42036580","source_url":"https://pubmed.ncbi.nlm.nih.gov/42036580/","doi":"10.1007/978-981-95-6872-7_23","pmid":"42036580","publication_date":"2026-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":339,"title":"Psychedelics: Future Therapeutics in Major Depression?","authors":"Olivier B, Olivier JDA","journal":"Advances in experimental medicine and biology","publication_date":"2026-01-01","publication_year":2026,"doi":"10.1007/978-981-95-6872-7_25","pubmed_id":"42036582","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/42036582/","substance_tags":"psilocybin","topic_tags":"Depression,Mechanism of Action,Receptor Pharmacology,Treatment-Resistant Depression,Safety,Adverse Events","study_type":"Other","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:04","last_checked":"2026-08-09 08:27:53","bibtex":null,"source_record_id":"PMID:42036582","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/42036582/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:42036582","source_url":"https://pubmed.ncbi.nlm.nih.gov/42036582/","doi":"10.1007/978-981-95-6872-7_25","pmid":"42036582","publication_date":"2026-01-01","importer_version":"2.1.3","text_redistributed":false}}],"total":4,"page":1,"per_page":20,"pages":1,"resource":"papers","filters":{"q":null,"author":null,"substances":["psilocybin","psilocin"],"topic":null,"study_type":null,"cited_doi":null,"sources":[],"publication_statuses":[],"year":null,"journal":"Advances in experimental medicine and biology","from":null,"to":null,"added_from":null,"added_to":null,"sort":"newly_added","page":1,"per_page":"20"}}